Nip Impressions logo
Sun, Dec 8, 2024 18:53
Visitor
Home
Click here for Pulp & Paper Radio International
Subscription Central
Must reads for pulp and paper industry professionals
Search
My Profile
Login
Logout
Management Side
Cascades Reports Results for the Third Quarter of 2024

Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2024.

Q3 2024 Highlights

  • Sales of $1,201 million (compared with $1,180 million in Q2 2024 and $1,198 million in Q3 2023);
  • Operating income of $36 million (compared with $34 million in Q2 2024 and $80 million in Q3 2023);
  • Net earnings per common share of $0.01 (compared with $0.01 in Q2 2024 and $0.34 in Q3 2023);
  • Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A)1) of $140 million (compared with $112 million in Q2 2024 and $161 million in Q3 2023);
  • Adjusted net earnings per common share1 of $0.27 (compared with $0.08 in Q2 2024 and $0.44 in Q3 2023);
  • Net debt1 of $2,039 million as of September 30, 2024 (compared with $2,093 million as of June 30, 2024). Net debt to EBITDA (A) ratio1 of 4.3x, versus from 4.2x as of June 30, 2024;
  • Total capital expenditures, net of disposals, totaled $34 million in Q3 2024, compared to $23 million in Q2 2024 and $56 million in Q3 2023. The Corporation's 2024 capital expenditures will be approximately $160 million.

Hugues Simon, President and CEO, commented: "We are pleased with our third quarter 2024 performance. Sequentially stronger results were driven by our Containerboard business, where higher average selling prices and lower production expenses offset the impact of higher raw material costs. Specialty Products results were stable, with stronger selling prices fully mitigating raw material cost and sales mix headwinds. As forecasted, third quarter Tissue Papers results were lower than the previous quarter due to higher average raw material costs and lower pricing related to the expected changes in the mix of products sold."

Discussing near-term outlook, Mr. Simon commented, "We expect fourth quarter results in each of our packaging business segments to be stable sequentially, as benefits from lower raw material costs and previously announced selling price increases will be offset by lower seasonal volumes. In Tissue Papers, slightly stronger sequential results are expected to benefit from lower average raw material costs, slightly stronger volumes, and selling price increase tailwinds offset by the impact from seasonal changes in sales mix.

As we look toward the medium and longer-term, we are focused on growing sustainable value for shareholders. Central to this is driving and capturing efficiency across our operational platforms, most notably by the ongoing scale-up of production at our Bear Island facility and ramp-up of our recently installed tissue converting lines. Prioritizing these areas, in conjunction with leveraging additional production capacity in all of our facilities through numerous efficiency optimization initiatives, will drive cash flow generation and debt reduction, both of which are key action areas across the Company. We will be all the more better positioned to deliver on both fronts as we implement the changes announced on October 30, and look forward to sharing details of our areas of strategic focus for the next 18 to 24 months in early 2025."

1

Some information represents non-IFRS Accounting Standards Financial measures, other financial measures or non-IFRS Accounting Standards ratios which are not standardized under IFRS Accounting Standards and therefore might not be comparable to similar financial measures disclosed by other corporations. Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation.

Financial Summary

Selected consolidated information

(in millions of Canadian dollars, except amounts per common share) (unaudited)

Q3 2024

Q2 2024

Q3 2023

Sales

1,201

1,180

1,198

As Reported

Operating income

36

34

80

Net earnings

1

1

34

per common share (basic)

$0.01

$0.01

$0.34

Adjusted1

Earnings before interest, taxes, depreciation and amortization (EBITDA (A))

140

112

161

Net earnings

27

8

45

per common share (basic)

$0.27

$0.08

$0.44

Margin (EBITDA (A) / Sales)

11.7 %

9.5 %

13.4 %

Segmented sales

(in millions of Canadian dollars) (unaudited)

Q3 2024

Q2 2024

Q3 2023

Packaging Products

Containerboard

610

585

593

Specialty Products

169

167

157

Inter-segment sales

(6)

(7)

(7)

773

745

743

Tissue Papers

390

397

422

Inter-segment sales, Corporate, Recovery and Recycling activities

38

38

33

Sales

1,201

1,180

1,198

Segmented operating income (loss)

(in millions of Canadian dollars) (unaudited)

Q3 2024

Q2 2024

Q3 2023

Packaging Products

Containerboard

24

15

61

Specialty Products

17

19

13

Tissue Papers

24

38

38

Corporate, Recovery and Recycling activities

(29)

(38)

(32)

Operating income

36

34

80

Segmented EBITDA (A)1

(in millions of Canadian dollars) (unaudited)

Q3 2024

Q2 2024

Q3 2023

Packaging Products

Containerboard

90

60

101

Specialty Products

27

26

21

Tissue Papers

43

54

61

Corporate, Recovery and Recycling activities

(20)

(28)

(22)

EBITDA (A)1

140

112

161

1 Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation.

Analysis of results for the three-month period ended September 30, 2024 (compared to the same period last year)

The Corporation's third quarter sales of $1,201 million increased by $3 million compared with the same period last year. This was driven by $24 million of sales mix benefits in Tissue Papers and Containerboard, and $12 million related to more a favourable foreign exchange. Results also reflected a consolidated $7 million net benefit from higher selling prices. These were offset by a net negative impact of $40 million related to lower volumes in Containerboard and Tissue Papers, with the majority of this impact attributable to the changes made within the Tissue Papers operational platform in the past year to improve profitability.

The third quarter EBITDA (A)1 totaled $140 million, a decrease of $21 million, or 13%, from the $161 million generated in the same period last year. This reflects consolidated net impacts of $35 million from higher raw material costs and $5 million related to volume and sales mix changes. These were partly offset by net benefits from higher selling prices and lower operating costs, and lower corporate costs, as expected.

The main specific items, before income taxes, that impacted our third quarter 2024 operating income and/or net earnings were:

  • $7 million of impairment charge on assets related to a decision to discontinue product lines in Canada and in the United States (operating income and net earnings);
  • $29 million of restructuring and other costs related to plant closures in Canada (operating income and net earnings);
  • $2 million unrealized gain on financial instruments (operating income and net earnings);
  • $2 million unrealized loss on interest rate hedge instruments (net earnings);
  • $1 million foreign exchange gain on long-term debt and financial instruments net earnings.

For the three-month period ended September 30, 2024, the Corporation posted net earnings of $1 million, or $0.01 per common share, compared to net earnings of $34 million, or $0.34 per common share, in the same period of 2023. On an adjusted basis1, the Corporation posted net earnings of $27 million in the third quarter of 2024, or $0.27 per common share, compared to net earnings of $45 million, or $0.44 per common share, in the same period of 2023.

1 Please refer to the "Supplemental Information on Non-IFRS Accounting Standards Measures and Other Financial Measures" section for a complete reconciliation.

Dividend on common shares and normal course issuer bid

The Board of Directors of Cascades declared a quarterly dividend of $0.12 per common share to be paid on December 5, 2024 to shareholders of record at the close of business on November 21, 2024. This dividend is an "eligible dividend" as per the Income Tax Act (R.C.S. (1985), Canada). During the third quarter of 2024, Cascades purchased no common shares for cancellation.

Ensure up to 50,000 Pulp and Paper professionals see your company as they search this directory.


Printer-friendly format

 





Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: